Article(id=1321501050578776995, tenantId=1146029695717560320, journalId=1246415837536497731, issueId=1321500868936052946, articleNumber=PA20260310_JzSx6fEe, orderNo=null, doi=10.12307/2026.025, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1743350400000, acceptedDateStr=2025-03-31, onlineDate=1748534400000, onlineDateStr=2025-05-30, pubDate=1767801600000, pubDateStr=2026-01-08, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793000002759, onlineIssueDateStr=2026-10-26, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793000002759, creator=admin, updateTime=1793000002759, updator=admin, issue=Issue{id=1321500868936052946, tenantId=1146029695717560320, journalId=1246415837536497731, year='2026', volume='30', issue='1', pageStart='null', pageEnd='null', issueExtLink='null', onlineDate='null', pubDate='1767801600000', pubDateStr='2026-01-08', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=0, articleOrder=1, issueType=-1, specialIssue=null, createTime=1792999959453, creator='ztmeta', updateTime=1792999959453, updator='ztmeta', preIssue=null, nextIssue=null, articleTotal=null, ext=null, issueFiles=null, downloadFileDto=null}, startPage=139, endPage=144, ext={EN=ArticleExt(id=1321501052629791653, articleId=1321501050578776995, tenantId=1146029695717560320, journalId=1246415837536497731, language=EN, title=Relationship between BCR/ABL gene expression and recurrence before and after allogeneic transplantation in Ph chromosome positive acute lymphoblastic leukemia, columnId=null, journalTitle=Chinese Journal of Tissue Engineering Research, columnName=工程化细胞或干细胞移植, runingTitle=null, highlight=null, articleAbstract=BACKGROUND: BCR/ABL gene is a specific gene of Ph chromosome-positive acute lymphoblastic leukemia, and its expression level has become a sensitive indicator for monitoring minimal residual disease before and after allogeneic hematopoietic stem cell transplantation. However, whether the expression level of BCR/ABL gene before transplantation affects the efficacy of transplantation and how to guide the early intervention of relapse with tyrosine kinase inhibitors after transplantation is still inconclusive.
OBJECTIVE: To explore the relationship between BCR/ABL gene expression and recurrence in patients with Ph chromosome positive acute lymphoblastic leukemia before and after related and allogeneic hematopoietic stem cell transplantation.
METHODS: Twenty-four patients with Ph chromosome positive acute lymphoblastic leukemia who achieved complete hematological remission and underwent allogeneic hematopoietic stem cell transplantation were selected at the Affiliated Hospital of North China University of Science and Technology between January 2015 and December 2022. Real time fluorescence quantitative polymerase chain reaction was used to dynamically detect the expression levels of BCR/ABL genes during treatment, representing minimal residual disease. Based on BCR/ABL gene expression, tyrosine kinase inhibitors combined with chemotherapy was administered before transplantation to select the timing of allogeneic hematopoietic stem cell transplantation. After transplantation, the disease status was evaluated to guide the use of tyrosine kinase inhibitors, and an early intervention plan for recurrence was developed.
RESULTS AND CONCLUSION: Follow-up was until December 2023, with a median follow-up time of 49 (12-82) months. There were 8 cases of hematological recurrence, with a median recurrence time of 14 (8-39) months and a cumulative recurrence rate of 33% (8/24). Univariate analysis showed that recurrence after allogeneic hematopoietic stem cell transplantation was not significantly correlated with gender, age, extramedullary complications, time from diagnosis to transplantation, HLA typing, acute graft-versus-host disease, and chronic graft-versus-host disease (P > 0.05). There was a significant correlation between the relief treatment course and minimal residual disease levels before transplantation. The second hematology completely resolution and positive minimal residual disease before transplantation had a higher hematological recurrence rate (P < 0.05). The 3-year cumulative recurrence rate, disease-free survival rate, and overall survival rate were 27%, 63%, and 74%; the 5-year cumulative recurrence rate, disease-free survival rate, and overall survival rate were 38%, 57%, and 74%, respectively. It is concluded that Ph chromosome positive acute lymphoblastic leukemia patients with BCR/ABL gene positive before transplantation have a higher recurrence rate. BCR/ABL gene expression after transplantation can guide the application of tyrosine kinase inhibitors and serve as a basis for early intervention in recurrence., authors=null, authorsList=null, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1321501052550099876, articleId=1321501050578776995, tenantId=1146029695717560320, journalId=1246415837536497731, language=CN, title=Ph染色体阳性急性淋巴细胞白血病移植前后BCR/ABL基因表达与复发的关系, columnId=null, journalTitle=中国组织工程研究, columnName=工程化细胞或干细胞移植, runingTitle=null, highlight=null, articleAbstract=BCR/ABL基因是Ph染色体阳性急性淋巴细胞白血病的特异性基因,其表达水平已经成为异基因造血干细胞移植前后微小残留病监测的敏感指标。然而,移植前BCR/ABL基因表达水平是否影响移植疗效,移植后如何指导酪氨酸激酶抑制剂进行复发的早期干预尚无定论。
目的:探讨Ph染色体阳性急性淋巴细胞白血病患者行亲缘间、异基因造血干细胞移植前后BCR/ABL基因表达与复发的关系。
方法:选择2015年1月至2022年12月期间华北理工大学附属医院收治的24例达到血液学完全缓解后行亲缘间异基因造血干细胞移植的Ph染色体阳性急性淋巴细胞白血病患者,应用实时荧光定量聚合酶链反应动态监测治疗期间BCR/ABL基因表达水平,以此代表微小残留病。依据BCR/ABL基因表达,移植前给予酪氨酸激酶抑制剂联合化疗,选择异基因造血干细胞移植时机;移植后评估疾病状态,指导酪氨酸激酶抑制剂的应用,制定早期干预复发的方案。
结果与结论:随访至2023年12月,中位随访时间为49(12-82)个月,8例血液学复发,复发的中位时间为14(8-39)个月,累积复发率为33%(8/24)。单因素分析显示,异基因造血干细胞移植后血液学复发与性别、年龄、髓外并发症、诊断至移植时间、HLA配型、急性移植物抗宿主病、慢性移植物抗宿主病无明显相关性(P > 0.05);与移植前缓解疗程及微小残留病水平有明显相关性,移植前第2次血液学完全缓解、微小残留病阳性患者有更高的血液学复发率(P < 0.05)。预期移植后3年累积复发率、无病生存率、总生存率分别为27%,63%,74%;5年累积复发率、无病生存率、总生存率分别为38%,57%,74%。结果表明,异基因造血干细胞移植前BCR/ABL基因阳性Ph染色体阳性急性淋巴细胞白血病患者有更高的复发率;移植后BCR/ABL基因表达可指导酪氨酸激酶抑制剂应用,做为早期干预复发的依据。, authors=null, authorsList=null, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=https://oss.bj-dx-dzqywjd-hlw-icp.inspurcloudoss.com:6063/cast-journal-prod/43b3e7ba8e754e91bcabe867b3e52989.pdf?response-content-disposition=attachment%3B%20filename%3D%22ABL%E5%9F%BA%E5%9B%A0%E8%A1%A8%E8%BE%BE%E4%B8%8E%E5%A4%8D%E5%8F%91%E7%9A%84%E5%85%B3%E7%B3%BB.pdf%22&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Date=20261026T073151Z&X-Amz-SignedHeaders=host&X-Amz-Expires=604800&X-Amz-Credential=NjRlNmUzOGMtM2Y3OC00MDQ3LThkMmYtN2JkODRmYmI3MTgw%2F20261026%2Fbj-dx-dzqywjd-hlw-icp%2Fs3%2Faws4_request&X-Amz-Signature=6dd32f2f57c48a033fca1e51b3748dfe38aed9b5324f62a38936b3761011df14, pdf=TcjKDyN0f4PhHXrlVWfBmg==, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null)}, authors=[Author(id=1321501052969530280, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=薛慧, orcid=0000-0001-9649-8736, stid=null, country=null, authorPic=null, dead=null, email=[], emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053091165098, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501052969530280, language=CN, stringName=薛慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=薛慧: 薛慧,女,1981年生,汉族,硕士,副主任医师,主要从事血液病的造血干细胞移植研究, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])]), Author(id=1321501053166662571, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=李东楠, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053242160045, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501053166662571, language=CN, stringName=李东楠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])]), Author(id=1321501053317657518, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=赵雅迪, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053393154992, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501053317657518, language=CN, stringName=赵雅迪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])]), Author(id=1321501053464458161, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=陈超, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053535761331, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501053464458161, language=CN, stringName=陈超, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])]), Author(id=1321501053602870196, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=谢宗源, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053665784758, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501053602870196, language=CN, stringName=谢宗源, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])])], keywords=[Keyword(id=1321501053770642359, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=CN, orderNo=1, keyword=急性淋巴细胞白血病), Keyword(id=1321501053837751224, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=CN, orderNo=2, keyword=异基因移植), Keyword(id=1321501053909054393, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=CN, orderNo=3, keyword=费城染色体), Keyword(id=1321501054009717690, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=CN, orderNo=4, keyword=BCR/ABL基因), Keyword(id=1321501054081020859, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=CN, orderNo=5, keyword=酪氨酸激酶抑制剂), Keyword(id=1321501054148129724, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=CN, orderNo=6, keyword=微小残留病), Keyword(id=1321501054211044285, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=CN, orderNo=7, keyword=早期干预), Keyword(id=1321501054299124670, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=CN, orderNo=8, keyword=复发), Keyword(id=1321501054349456319, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=EN, orderNo=1, keyword=acute lymphoblastic leukemia), Keyword(id=1321501054403982272, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=EN, orderNo=2, keyword=allogeneic transplantation), Keyword(id=1321501054475285441, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=EN, orderNo=3, keyword=philadelphia chromosome), Keyword(id=1321501054538200002, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=EN, orderNo=4, keyword=BCR/ABL gene), Keyword(id=1321501054609503171, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=EN, orderNo=5, keyword=tyrosine kinase inhibitor), Keyword(id=1321501054672417732, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=EN, orderNo=6, keyword=minimal residual disease), Keyword(id=1321501054731137989, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=EN, orderNo=7, keyword=early intervention), Keyword(id=1321501054827606982, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, language=EN, orderNo=8, keyword=recurrence)], refs=[Reference(id=1321501055142179785, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=WILLYANTO SE, ALIMSJAH YA, TANJAYA K, et al. Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis. Ann Med. 2024;56(1):2349796., articleTitle=null, refAbstract=null), Reference(id=1321501055146374090, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=NAGLER A, LABOPIN M, DHOLARIA B, et al. Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. Br J Haematol. 2019; 186(5):767-776., articleTitle=null, refAbstract=null), Reference(id=1321501055146374091, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=KHIMANI F, DUTTA M, FARAMAND R, et al. Impact of Total Body Irradiation-Based Myeloablative Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis. Transplant Cell Ther. 2021;27(7):620.e1-620.e9., articleTitle=null, refAbstract=null), Reference(id=1321501055146374092, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=BADAR T, NARRA R, MIMS AS, et al. Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study. Am J Hematol. 2024;99(12):2388-2391., articleTitle=null, refAbstract=null), Reference(id=1321501055146374093, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=王萌,张靖岚,邢海洲,等.移植前微小残留病状态对行异基因造血干细胞移植的急性淋巴细胞白血病患者预后的影响[J].中华实用诊断与治疗杂志,2023,37(2):124-128., articleTitle=null, refAbstract=null), Reference(id=1321501055146374094, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO W, ZHANG H, ZHENG Y, et al. Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT. Ann Hematol. 2024;103(8):3155-3163., articleTitle=null, refAbstract=null), Reference(id=1321501055146374095, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=曹星玉,马薇,张薇,等.酪氨酸激酶抑制剂时代完全缓解状态下Ph染色体阳性急性淋巴细胞白血病异基因造血干细胞移植预后分析[J].中华血液学杂志,2020,41(7):564-569., articleTitle=null, refAbstract=null), Reference(id=1321501055146374096, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=中国抗癌协会血液肿瘤专业委员会,中华医学会血液学分会白血病淋巴瘤学组.中国成人急性淋巴细胞白血病诊断与治疗指南(2021年版)[J].中华血液学杂志,2021,42(9):705-716., articleTitle=null, refAbstract=null), Reference(id=1321501055146374097, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=PFEIFER H, CAZZANIGA G, VAN DER VELDEN VHJ, et al. Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia. 2019;33(8):1910-1922., articleTitle=null, refAbstract=null), Reference(id=1321501055146374098, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=VAN DER ZOUWEN B, KOSTER EAS, VON DEM BORNE PA, et al. Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients. Ann Hematol. 2023;102(5):1203-1213., articleTitle=null, refAbstract=null), Reference(id=1321501055146374099, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=BADER P, ROSSIG C, HUTTER M, et al. CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany. Blood Adv. 2023;7(11):2436-2448., articleTitle=null, refAbstract=null), Reference(id=1321501055146374100, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=GOOPTU M, KIM HT, HO VT, et al. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis. Biol Blood Marrow Transplant. 2018;24(8):1733-1740., articleTitle=null, refAbstract=null), Reference(id=1321501055146374101, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=SHAHZAD M, HUSSAIN A, TARIQ E, et al. Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis. Clin Lymphoma Myeloma Leuk. 2023;23(3):178-187., articleTitle=null, refAbstract=null), Reference(id=1321501055146374102, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=GOLDSMITH SR, SLADE M, DIPERSIO JF, et al. Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy. Bone Marrow Transplant. 2017;52(12):1623-1628., articleTitle=null, refAbstract=null), Reference(id=1321501055146374103, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=MINCULESCU L, REEKIE J, PETERSEN SL, et al. Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation. Acta Haematol. 2024;147(3):, articleTitle=null, refAbstract=null), Reference(id=1321501055146374104, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=CANDONI A, RAMBALDI A, FANIN R, et al. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO). Biol Blood Marrow Transplant. 2019;25(12):2388-2397., articleTitle=null, refAbstract=null), Reference(id=1321501055146374105, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=SMITH K, FATHOALA D, ANTHIAS C, et al. Venetoclax-based salvage for management of relapsed acute leukaemia after allogeneic haematopoetic stem cell transplant: durable remissions only seen following consolidation with donor lymphocyte infusion or second transplant. Bone Marrow Transplant. 2023;58(10):1152-1156., articleTitle=null, refAbstract=null), Reference(id=1321501055146374106, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU S, DENG B, YIN Z, et al. Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation. Am J Hematol. 2021;96(6):671-679., articleTitle=null, refAbstract=null), Reference(id=1321501055146374107, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=张之南,郝玉书,赵永强,等.血液病学[M].2版.北京:人民卫生出版社,2012:719-730., articleTitle=null, refAbstract=null), Reference(id=1321501055146374108, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=TAN JL, CURTIS DJ, MUIRHEAD J, et al. CD34 Chimerism Directed Donor Lymphocyte Infusion With or Without Azacitidine Results in Reduced Relapse and Superior Overall Survival When Full Donor Chimerism is Achieved in Allogeneic Stem Cell Transplant Recipients With Acute Myeloid Leukaemia/Myelodysplastic Syndrome. Clin Lymphoma Myeloma Leuk. 2024;24(11):e852-e860., articleTitle=null, refAbstract=null), Reference(id=1321501055146374109, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=LI Q, LYU C, LIU M, et al. Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant. Cell Transplant. 2023;32: 9636897231158155., articleTitle=null, refAbstract=null), Reference(id=1321501055146374110, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=TAN X, WANG XQ, ZHANG C, et al. Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation. Curr Med Sci. 2023;43(4):733-740., articleTitle=null, refAbstract=null), Reference(id=1321501055146374111, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=GUAN F, YANG L, CHEN Y, et al. Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study. Cancer. 2024;130(12):2139-2149., articleTitle=null, refAbstract=null), Reference(id=1321501055146374112, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=王志东,李思琦,孙于谦,等.微小残留病阳性提示异基因移植前疾病状态处于完全缓解2及以上的急性淋巴细胞白血病患者的预后欠佳[J].中华检验医学杂志,2021,44(12):1145-1152., articleTitle=null, refAbstract=null), Reference(id=1321501055146374113, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=李渊,王冰洁,刘微,等.达沙替尼联合化疗序贯异基因造血干细胞移植治疗Ph染色体阳性急性淋巴细胞白血病的临床分析[J].中国实验血液学杂志,2020,28(1):18-23., articleTitle=null, refAbstract=null), Reference(id=1321501055146374114, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=325-332., articleTitle=null, refAbstract=null), Reference(id=1321501055150568395, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=CHALANDON Y, THOMAS X, HAYETTE S, et al. Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia. Blood. 2015;125(24):3711-3719., articleTitle=null, refAbstract=null), Reference(id=1321501055150568396, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=王洋,徐晓曼,张民,等.费城染色体核型和异基因造血干细胞移植对急性淋巴细胞白血病患者疗效的影响[J].中国实验血液学杂志,2022,30(5):1397-1406., articleTitle=null, refAbstract=null), Reference(id=1321501055150568397, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=CHOI Y, CHOI EJ, LEE JH, et al. Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2021;35(3):e14199., articleTitle=null, refAbstract=null), Reference(id=1321501055150568398, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAUVET P, PAVIGLIANITI A, LABOPIN M, et al. Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC. Bone Marrow Transplant. 2023;58(1):72-79., articleTitle=null, refAbstract=null), Reference(id=1321501055150568399, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=XU LP, LU PH, WU DP, et al. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transplant. 2021; 56(12):2940-2947., articleTitle=null, refAbstract=null), Reference(id=1321501055150568400, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=WARRAICH Z, TENNETI P, THAI T, et al. Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic Review. Biol Blood Marrow Transplant. 2020;26(3): e55-e64., articleTitle=null, refAbstract=null)], funds=[Fund(id=1321501054924075975, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, awardId=2031066712750247937, language=CN, fundingSource=河北省省级科技计划资助, fundOrder=null, country=null), Fund(id=1321501055028933576, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, awardId=2031066712750247938, language=CN, fundingSource=河北省医学科学研究课题计划资助, fundOrder=null, country=null)], companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])], figs=null, attaches=null, journal=Journal(id=1246415294369935424, delFlag=0, nameCn=中国组织工程研究, nameEn=Chinese Journal of Tissue Engineering Research, nameHistory1=null, nameHistory2=null, issn=2095-4344, eissn=null, cn=21-1581/R, coden=null, periodic=4, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=Z8GUGTZyRoc+cZI9v+UXIQ==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Tissue Engineering Research, journalRemark=null, publicationField=null, createdTime=1775098163455, updatedTime=1784020022996, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Life Sciences, subjectName=null, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=Z8GUGTZyRoc+cZI9v+UXIQ==, picEn=sS3E3RhpIvw/+mCxJnlQjw==, jcr=null, cjcr=null, exts=[JournalExt(id=1283836286578443023, language=CN, name=中国组织工程研究, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1784020023245, updatedTime=1784020023245, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgzzgcauthor.manuscriptcloud.com/, submissionEditorUrl=https://zgzzgceditor.manuscriptcloud.com/, submissionReviewUrl=https://zgzzgcauthor.manuscriptcloud.com/, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1283836286641357584, language=EN, name=Chinese Journal of Tissue Engineering Research, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1784020023260, updatedTime=1784020023260, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgzzgcauthor.manuscriptcloud.com/, submissionEditorUrl=https://zgzzgceditor.manuscriptcloud.com/, submissionReviewUrl=https://zgzzgcauthor.manuscriptcloud.com/, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1246415837536497731, websiteList=[Website(id=1246421196720460703, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1246415837536497731, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgzzgcyj/CN, language=CN, createTime=1775099570684, createBy=18614031015, updateTime=1775100523356, updateBy=18614031015, name=中国组织工程研究-中文, tplId=1146099689490845704, title=中国组织工程研究, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1246425325081613254, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=articleTextType, value=kx, createTime=1775100554962, updateTime=1775100554962, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425325052253123, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=banner, value=null, createTime=1775100554955, updateTime=1775100554955, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425325110973385, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=grayFlag, value=0, createTime=1775100554969, updateTime=1775100554969, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425325043864514, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=logo, value=https://castjournals.cast.org.cn/joweb/zgzzgcyj/CN/file/pic?fileId=3HSzTUf/nj4CbNAHtU7s5g==, createTime=1775100554953, updateTime=1775100554953, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425325123556299, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=minRunFlag, value=0, createTime=1775100554972, updateTime=1775100554972, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425325073224645, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgzzgcyj/CN/file/pic, createTime=1775100554960, updateTime=1775100554960, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425325115167690, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=silenceFlag, value=0, createTime=1775100554970, updateTime=1775100554970, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425325064836036, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1775100554958, updateTime=1775100554958, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425325094196167, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=themeColor, value=null, createTime=1775100554965, updateTime=1775100554965, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425325102584776, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196720460703, code=themeStyle, value=null, createTime=1775100554967, updateTime=1775100554967, creator=18614031015, updator=18614031015)]), Website(id=1246421196875649954, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1246415837536497731, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgzzgcyj/EN, language=EN, createTime=1775099570721, createBy=18614031015, updateTime=1775100518855, updateBy=18614031015, name=中国组织工程研究-英文, tplId=1146101810881728533, title=Chinese Journal of Tissue Engineering Research, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1246425360989053080, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=articleTextType, value=kx, createTime=1775100563523, updateTime=1775100563523, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425360968081557, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=banner, value=null, createTime=1775100563518, updateTime=1775100563518, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425361014218907, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=grayFlag, value=0, createTime=1775100563529, updateTime=1775100563529, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425360955498644, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=logo, value=https://castjournals.cast.org.cn/joweb/zgzzgcyj/EN/file/pic?fileId=3HSzTUf/nj4CbNAHtU7s5g==, createTime=1775100563515, updateTime=1775100563515, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425361030996125, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=minRunFlag, value=0, createTime=1775100563533, updateTime=1775100563533, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425360984858775, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgzzgcyj/EN/file/pic, createTime=1775100563522, updateTime=1775100563522, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425361018413212, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=silenceFlag, value=0, createTime=1775100563530, updateTime=1775100563530, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425360976470166, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1775100563520, updateTime=1775100563520, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425360997441689, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=themeColor, value=null, createTime=1775100563525, updateTime=1775100563525, creator=18614031015, updator=18614031015), WebsiteProps(id=1246425361005830298, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196875649954, code=themeStyle, value=null, createTime=1775100563527, updateTime=1775100563527, creator=18614031015, updator=18614031015)])], journalTitle=中国组织工程研究, weixinUrl=null, journalUrl=https://www.cjter.com/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Tissue Engineering Research, journalPhotoCn=Z8GUGTZyRoc+cZI9v+UXIQ==, journalPhotoEn=sS3E3RhpIvw/+mCxJnlQjw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgzzgcyj/CN/10.12307/2026.025, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgzzgcyj/EN/10.12307/2026.025, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgzzgcyj/CN/PDF/10.12307/2026.025, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgzzgcyj/EN/PDF/10.12307/2026.025, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1767801600000, fullTextJson=null, articleText=null, reference=null)
中国组织工程研究
|工程化细胞或干细胞移植
2026
, 30
(1) :
139
-144
Ph染色体阳性急性淋巴细胞白血病移植前后BCR/ABL基因表达与复发的关系
全屏
[Author(id=1321501052969530280, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=薛慧, orcid=0000-0001-9649-8736, stid=null, country=null, authorPic=null, dead=null, email=[], emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053091165098, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501052969530280, language=CN, stringName=薛慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=薛慧: 薛慧,女,1981年生,汉族,硕士,副主任医师,主要从事血液病的造血干细胞移植研究, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])]), Author(id=1321501053166662571, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=李东楠, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053242160045, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501053166662571, language=CN, stringName=李东楠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])]), Author(id=1321501053317657518, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=赵雅迪, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053393154992, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501053317657518, language=CN, stringName=赵雅迪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])]), Author(id=1321501053464458161, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=陈超, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053535761331, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501053464458161, language=CN, stringName=陈超, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])]), Author(id=1321501053602870196, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=谢宗源, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=2, ext={CN=AuthorExt(id=1321501053665784758, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, authorId=1321501053602870196, language=CN, stringName=谢宗源, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1 , address=1. 北理工大学附属医院血液科,河北省唐山市 063000北理工大学附属医院血液科,河北省唐山市 063000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1321501052801758118, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, xref=1, ext=[AuthorCompanyExt(id=1321501052814341031, tenantId=1146029695717560320, journalId=1246415837536497731, articleId=1321501050578776995, companyId=1321501052801758118, language=CN, country=null, province=null, city=null, postcode=null, companyName=北理工大学附属医院血液科,河北省唐山市 063000, departmentName=null, remark=1. 北理工大学附属医院血液科,河北省唐山市 063000)])])]
薛慧 1
,
李东楠 1 ,
赵雅迪 1 ,
陈超 1 ,
谢宗源 1
作者信息
Relationship between BCR/ABL gene expression and recurrence before and after allogeneic transplantation in Ph chromosome positive acute lymphoblastic leukemia
Affiliations
出版时间: 2026-01-08
doi: 10.12307/2026.025
文章导航
BCR/ABL基因是Ph染色体阳性急性淋巴细胞白血病的特异性基因,其表达水平已经成为异基因造血干细胞移植前后微小残留病监测的敏感指标。然而,移植前BCR/ABL基因表达水平是否影响移植疗效,移植后如何指导酪氨酸激酶抑制剂进行复发的早期干预尚无定论。
目的:探讨Ph染色体阳性急性淋巴细胞白血病患者行亲缘间、异基因造血干细胞移植前后BCR/ABL基因表达与复发的关系。
方法:选择2015年1月至2022年12月期间华北理工大学附属医院收治的24例达到血液学完全缓解后行亲缘间异基因造血干细胞移植的Ph染色体阳性急性淋巴细胞白血病患者,应用实时荧光定量聚合酶链反应动态监测治疗期间BCR/ABL基因表达水平,以此代表微小残留病。依据BCR/ABL基因表达,移植前给予酪氨酸激酶抑制剂联合化疗,选择异基因造血干细胞移植时机;移植后评估疾病状态,指导酪氨酸激酶抑制剂的应用,制定早期干预复发的方案。
结果与结论:随访至2023年12月,中位随访时间为49(12-82)个月,8例血液学复发,复发的中位时间为14(8-39)个月,累积复发率为33%(8/24)。单因素分析显示,异基因造血干细胞移植后血液学复发与性别、年龄、髓外并发症、诊断至移植时间、HLA配型、急性移植物抗宿主病、慢性移植物抗宿主病无明显相关性(P > 0.05);与移植前缓解疗程及微小残留病水平有明显相关性,移植前第2次血液学完全缓解、微小残留病阳性患者有更高的血液学复发率(P < 0.05)。预期移植后3年累积复发率、无病生存率、总生存率分别为27%,63%,74%;5年累积复发率、无病生存率、总生存率分别为38%,57%,74%。结果表明,异基因造血干细胞移植前BCR/ABL基因阳性Ph染色体阳性急性淋巴细胞白血病患者有更高的复发率;移植后BCR/ABL基因表达可指导酪氨酸激酶抑制剂应用,做为早期干预复发的依据。
急性淋巴细胞白血病
/
异基因移植
/
费城染色体
/
BCR/ABL基因
/
酪氨酸激酶抑制剂
/
微小残留病
/
早期干预
/
复发
BACKGROUND: BCR/ABL gene is a specific gene of Ph chromosome-positive acute lymphoblastic leukemia, and its expression level has become a sensitive indicator for monitoring minimal residual disease before and after allogeneic hematopoietic stem cell transplantation. However, whether the expression level of BCR/ABL gene before transplantation affects the efficacy of transplantation and how to guide the early intervention of relapse with tyrosine kinase inhibitors after transplantation is still inconclusive.
OBJECTIVE: To explore the relationship between BCR/ABL gene expression and recurrence in patients with Ph chromosome positive acute lymphoblastic leukemia before and after related and allogeneic hematopoietic stem cell transplantation.
METHODS: Twenty-four patients with Ph chromosome positive acute lymphoblastic leukemia who achieved complete hematological remission and underwent allogeneic hematopoietic stem cell transplantation were selected at the Affiliated Hospital of North China University of Science and Technology between January 2015 and December 2022. Real time fluorescence quantitative polymerase chain reaction was used to dynamically detect the expression levels of BCR/ABL genes during treatment, representing minimal residual disease. Based on BCR/ABL gene expression, tyrosine kinase inhibitors combined with chemotherapy was administered before transplantation to select the timing of allogeneic hematopoietic stem cell transplantation. After transplantation, the disease status was evaluated to guide the use of tyrosine kinase inhibitors, and an early intervention plan for recurrence was developed.
RESULTS AND CONCLUSION: Follow-up was until December 2023, with a median follow-up time of 49 (12-82) months. There were 8 cases of hematological recurrence, with a median recurrence time of 14 (8-39) months and a cumulative recurrence rate of 33% (8/24). Univariate analysis showed that recurrence after allogeneic hematopoietic stem cell transplantation was not significantly correlated with gender, age, extramedullary complications, time from diagnosis to transplantation, HLA typing, acute graft-versus-host disease, and chronic graft-versus-host disease (P > 0.05). There was a significant correlation between the relief treatment course and minimal residual disease levels before transplantation. The second hematology completely resolution and positive minimal residual disease before transplantation had a higher hematological recurrence rate (P < 0.05). The 3-year cumulative recurrence rate, disease-free survival rate, and overall survival rate were 27%, 63%, and 74%; the 5-year cumulative recurrence rate, disease-free survival rate, and overall survival rate were 38%, 57%, and 74%, respectively. It is concluded that Ph chromosome positive acute lymphoblastic leukemia patients with BCR/ABL gene positive before transplantation have a higher recurrence rate. BCR/ABL gene expression after transplantation can guide the application of tyrosine kinase inhibitors and serve as a basis for early intervention in recurrence.
acute lymphoblastic leukemia
/
allogeneic transplantation
/
philadelphia chromosome
/
BCR/ABL gene
/
tyrosine kinase inhibitor
/
minimal residual disease
/
early intervention
/
recurrence
薛慧, 李东楠, 赵雅迪, 陈超, 谢宗源.
Ph染色体阳性急性淋巴细胞白血病移植前后BCR/ABL基因表达与复发的关系.
中国组织工程研究,
2026
, 30
(1)
: 139
-144
.
DOI: 10.12307/2026.025
.
Relationship between BCR/ABL gene expression and recurrence before and after allogeneic transplantation in Ph chromosome positive acute lymphoblastic leukemia[J].
Chinese Journal of Tissue Engineering Research ,
2026
, 30
(1)
: 139
-144
.
DOI: 10.12307/2026.025
河北省省级科技计划资助
河北省医学科学研究课题计划资助
参考文献
引证文献
1
WILLYANTO SE, ALIMSJAH YA, TANJAYA K, et al. Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis. Ann Med. 2024;56(1):2349796.
2
NAGLER A, LABOPIN M, DHOLARIA B, et al. Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. Br J Haematol. 2019; 186(5):767-776.
3
KHIMANI F, DUTTA M, FARAMAND R, et al. Impact of Total Body Irradiation-Based Myeloablative Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis. Transplant Cell Ther. 2021;27(7):620.e1-620.e9.
4
BADAR T, NARRA R, MIMS AS, et al. Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study. Am J Hematol. 2024;99(12):2388-2391.
5
王萌,张靖岚,邢海洲,等.移植前微小残留病状态对行异基因造血干细胞移植的急性淋巴细胞白血病患者预后的影响[J].中华实用诊断与治疗杂志,2023,37(2):124-128.
6
GUO W, ZHANG H, ZHENG Y, et al. Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT. Ann Hematol. 2024;103(8):3155-3163.
7
曹星玉,马薇,张薇,等.酪氨酸激酶抑制剂时代完全缓解状态下Ph染色体阳性急性淋巴细胞白血病异基因造血干细胞移植预后分析[J].中华血液学杂志,2020,41(7):564-569.
8
中国抗癌协会血液肿瘤专业委员会,中华医学会血液学分会白血病淋巴瘤学组.中国成人急性淋巴细胞白血病诊断与治疗指南(2021年版)[J].中华血液学杂志,2021,42(9):705-716.
9
PFEIFER H, CAZZANIGA G, VAN DER VELDEN VHJ, et al. Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia. 2019;33(8):1910-1922.
10
VAN DER ZOUWEN B, KOSTER EAS, VON DEM BORNE PA, et al. Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients. Ann Hematol. 2023;102(5):1203-1213.
11
BADER P, ROSSIG C, HUTTER M, et al. CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany. Blood Adv. 2023;7(11):2436-2448.
12
GOOPTU M, KIM HT, HO VT, et al. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis. Biol Blood Marrow Transplant. 2018;24(8):1733-1740.
13
SHAHZAD M, HUSSAIN A, TARIQ E, et al. Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis. Clin Lymphoma Myeloma Leuk. 2023;23(3):178-187.
14
GOLDSMITH SR, SLADE M, DIPERSIO JF, et al. Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy. Bone Marrow Transplant. 2017;52(12):1623-1628.
15
MINCULESCU L, REEKIE J, PETERSEN SL, et al. Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation. Acta Haematol. 2024;147(3):
16
CANDONI A, RAMBALDI A, FANIN R, et al. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO). Biol Blood Marrow Transplant. 2019;25(12):2388-2397.
17
SMITH K, FATHOALA D, ANTHIAS C, et al. Venetoclax-based salvage for management of relapsed acute leukaemia after allogeneic haematopoetic stem cell transplant: durable remissions only seen following consolidation with donor lymphocyte infusion or second transplant. Bone Marrow Transplant. 2023;58(10):1152-1156.
18
LIU S, DENG B, YIN Z, et al. Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation. Am J Hematol. 2021;96(6):671-679.
19
张之南,郝玉书,赵永强,等.血液病学[M].2版.北京:人民卫生出版社,2012:719-730.
20
TAN JL, CURTIS DJ, MUIRHEAD J, et al. CD34 Chimerism Directed Donor Lymphocyte Infusion With or Without Azacitidine Results in Reduced Relapse and Superior Overall Survival When Full Donor Chimerism is Achieved in Allogeneic Stem Cell Transplant Recipients With Acute Myeloid Leukaemia/Myelodysplastic Syndrome. Clin Lymphoma Myeloma Leuk. 2024;24(11):e852-e860.
21
LI Q, LYU C, LIU M, et al. Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant. Cell Transplant. 2023;32: 9636897231158155.
22
TAN X, WANG XQ, ZHANG C, et al. Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation. Curr Med Sci. 2023;43(4):733-740.
23
GUAN F, YANG L, CHEN Y, et al. Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study. Cancer. 2024;130(12):2139-2149.
24
王志东,李思琦,孙于谦,等.微小残留病阳性提示异基因移植前疾病状态处于完全缓解2及以上的急性淋巴细胞白血病患者的预后欠佳[J].中华检验医学杂志,2021,44(12):1145-1152.
25
李渊,王冰洁,刘微,等.达沙替尼联合化疗序贯异基因造血干细胞移植治疗Ph染色体阳性急性淋巴细胞白血病的临床分析[J].中国实验血液学杂志,2020,28(1):18-23.
27
CHALANDON Y, THOMAS X, HAYETTE S, et al. Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia. Blood. 2015;125(24):3711-3719.
28
王洋,徐晓曼,张民,等.费城染色体核型和异基因造血干细胞移植对急性淋巴细胞白血病患者疗效的影响[J].中国实验血液学杂志,2022,30(5):1397-1406.
29
CHOI Y, CHOI EJ, LEE JH, et al. Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2021;35(3):e14199.
30
CHAUVET P, PAVIGLIANITI A, LABOPIN M, et al. Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC. Bone Marrow Transplant. 2023;58(1):72-79.
31
XU LP, LU PH, WU DP, et al. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transplant. 2021; 56(12):2940-2947.
32
WARRAICH Z, TENNETI P, THAI T, et al. Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic Review. Biol Blood Marrow Transplant. 2020;26(3): e55-e64.
2026年第30卷第1期
PDF下载
34
8
引用本文
BibTeX
文章信息
doi: 10.12307/2026.025
首发时间:2025-05-30
出版时间:2026-01-08
河北省省级科技计划资助
河北省医学科学研究课题计划资助
https://castjournals.cast.org.cn/joweb/zgzzgcyj/CN/10.12307/2026.025
复制链接
引用本文
BibTeX
2种不同金属材料的力学参数
科 Family 属数 Number of genus 种数 Number of species 占总种数比例 Percentage of total species (%) 属 Genus 种数 Number of species 占总种数比例 Percentage of total species (%) 鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78 小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39 多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39 红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87 小菇属 Mycena 11 5.26 光柄菇属 Pluteus 5 2.39 红菇属 Russula 17 8.13 栓菌属 Trametes 5 2.39
关闭全屏
BibTeX
EndNote
RefWorks
TxT